Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase enzyme immunoassay for Chlamydial antibodies.

P Saikku, J Paavonen, P Väänänen

    Journal of Clinical Microbiology
    |January 1, 1983
    PubMed
    Summary

    A new enzyme immunoassay (EIA) accurately detects immunoglobulin G antibodies for Chlamydia trachomatis infections. This diagnostic tool shows high correlation with established methods, offering a reliable option for chlamydial disease detection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern.

    Epidemiology and infection·2002
    Same author

    Tissue plasminogen activator as a key effector in neurobiology and neuropathology.

    Biochemical Society transactions·2002
    Same author

    Antibody status to HHV-6 in children with leukaemia.

    Leukemia·2002
    Same author

    Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus.

    Viral immunology·2002
    Same author

    [Gene amplification methods in viral diagnostics].

    Duodecim; laaketieteellinen aikakauskirja·2002
    Same author

    Chlamydia trachomatis infection in mothers with preterm delivery and in their newborn infants.

    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2002

    Area of Science:

    • Immunology
    • Microbiology
    • Diagnostic Development

    Background:

    • Chlamydia trachomatis infections require sensitive diagnostic methods.
    • Existing serological tests for chlamydial immunoglobulin G (IgG) antibodies have limitations.
    • Development of novel immunoassays is crucial for improved diagnostics.

    Purpose of the Study:

    • To develop and validate a novel enzyme immunoassay (EIA) for detecting Chlamydia trachomatis-specific IgG antibodies.
    • To assess the diagnostic performance of the developed EIA against established immunofluorescence tests.
    • To identify the key antigenic components utilized in the EIA.

    Main Methods:

    • Developed an EIA using microtiter wells coated with partially purified reticulate bodies of Chlamydia trachomatis serotype L2.

    Related Experiment Videos

  • Utilized uninfected McCoy cells as a control in the EIA.
  • Compared EIA results with inclusion immunofluorescence and micro-immunofluorescence tests using patient sera.
  • Performed immunoblotting to characterize the antigenic components of the EIA.

    • Main Results:

    • The EIA demonstrated a good correlation with both inclusion immunofluorescence (421 sera) and micro-immunofluorescence tests (140 sera).
    • Sera from healthy individuals (77) showed negative results in the EIA.
    • Immunoblotting identified a 39,000 molecular weight protein as the major antigenic component in the EIA.

    Conclusions:

    • The developed enzyme immunoassay is a sensitive and specific method for detecting Chlamydia trachomatis IgG antibodies.
    • The EIA shows excellent correlation with established serological diagnostic techniques.
    • The assay's reliance on a specific 39 kDa protein suggests a targeted and potentially robust diagnostic approach.